Michael Osthoff
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 36
- Pneumonia and Respiratory Infections 10
-
- Antimicrobial Resistance in Staphylococcus 9
- COVID-19 Clinical Research Studies 8
- Co-authors
- Stefano Bassetti (23 shared papers)Adrian Egli (16 shared papers)Marten Trendelenburg (23 shared papers)Damon P. Eisen (8 shared papers)Sarah Tschudin‐Sutter (5 shared papers)Sarah L. McGuinness (1 shared paper)Aaron Z. Wagen (1 shared paper)Maja Weisser (9 shared papers)
- Journals
- Frontiers in Immunology (6 papers)Swiss Medical Weekly (5 papers)PLoS ONE (5 papers)Frontiers in Medicine (4 papers)AIDS (3 papers)
- Partner nations
- SwitzerlandChileAustralia
In The Last Decade
Michael Osthoff
86 papers receiving 1.6k citations
Michael Osthoff's Hit Papers
Peers
Comparison fields: 5 of 135
- Applied Microbiology and Biotechnology 193
- Molecular Medicine 183
- Clinical Biochemistry 213
- Infectious Diseases 317
- Immunology 353
Countries citing papers authored by Michael Osthoff
This map shows the geographic impact of Michael Osthoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Osthoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Osthoff more than expected).
Fields of papers citing papers by Michael Osthoff
This network shows the impact of papers produced by Michael Osthoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Osthoff. The network helps show where Michael Osthoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Osthoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning Hit paper breakdown → | 2022 | 140 |
| 2 | Optimizing antibiotic therapies to reduce the risk of bacterial resistance Hit paper breakdown → | 2022 | 114 |
| 3 | 2015 | 94 | |
| 4 | 2022 | 77 | |
| 5 | 2011 | 73 | |
| 6 | 2016 | 66 | |
| 7 | 2009 | 60 | |
| 8 | 2020 | 58 | |
| 9 | 2020 | 44 | |
| 10 | 2018 | 41 | |
| 11 | 2016 | 39 | |
| 12 | 2021 | 37 | |
| 13 | 2014 | 34 | |
| 14 | 2012 | 34 | |
| 15 | 2020 | 33 | |
| 16 | 2015 | 26 | |
| 17 | 2013 | 23 | |
| 18 | 2013 | 21 | |
| 19 | 2017 | 21 | |
| 20 | 2015 | 21 |
About Michael Osthoff
Michael Osthoff is a scholar working on Epidemiology, Infectious Diseases, Immunology, Pharmacology and Clinical Biochemistry, having authored 94 papers that have together received 1.6k indexed citations. Recurring topics across this work include Complement system in diseases (19 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Bacterial Identification and Susceptibility Testing (11 papers), Pneumonia and Respiratory Infections (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotic Use and Resistance (9 papers), COVID-19 Clinical Research Studies (8 papers) and Antibiotic Resistance in Bacteria (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (193 citations), Molecular Medicine (183 citations), Clinical Biochemistry (213 citations), Infectious Diseases (317 citations) and Immunology (353 citations). Michael Osthoff has collaborated with scholars based in Switzerland, Chile and Australia. Frequent co-authors include Stefano Bassetti, Adrian Egli, Marten Trendelenburg, Damon P. Eisen, Sarah Tschudin‐Sutter, Sarah L. McGuinness, Aaron Z. Wagen, Maja Weisser, Monica Schaller and G Balestra. Their work appears in journals such as Frontiers in Immunology, Swiss Medical Weekly, PLoS ONE, Frontiers in Medicine and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.